Career Contact Us Sitemap Search
  Manufacturing Resources Research Global Disease Initiative Investor Relations Strides Worldwide Products Press Room
 
 
   
 
 
 
Strides has launched Starflu (Oseltamivir) for the treatment of ‘Influenza – A (H1N1)’ in the retail market. Starflu is available in 75 mg capsules in a strip of 10’s, the MRP for which is Rs. 460/-

The retail effort for Starflu is being carried out by Domestic Critical Care Division of Strides Arcolab. Starflu is being made available in the 480 odd designated chemists/pharmacies with the required schedule X license.

For further details and for business enquiries, you can contact us at 080-66580739/230 or at Silwin.nr@stridesarco.com / Shamit.g@stridesarco.com.